Strategic Capital

Strategic Capital 2024-09-25T19:27:56+00:00

Identifying and acting on opportunities.

Sectors of Focus

50mil - Strategic Capital
FLEXIBLE ACQUISITION RANGE & STRUCTURE
11x - Strategic Capital
AVERAGE EQUITY MOIC ON DIRECT INVESTMENTS
10 - Strategic Capital
DIRECT & CO-INVEST PLATFORMS

Identifying and acting on opportunities.

Sectors of Focus

icon pharma - Strategic Capital
PHARMA
icon services - Strategic Capital
PHARMA SERVICES
icon health - Strategic Capital
CONSUMER HEALTH

Typical Transaction
Direct investments where we partner with management or other sponsors

REPRESENTATIVE INVESTMENTS

logo-covis

Covis Pharma is a global pharma company focused on revitalizing deprioritized brands and promoting niche products.

SECTOR: Pharma
YEAR: December 2011
STATUS: Realized
PE PARTNER: Cerberus Capital Management

logo-tanner

Tanner Pharma Group is a pharma services company specializing in global patient access and clinical development programs.

SECTOR: Pharma Services
YEAR: January 2011
STATUS: Current

logo – curia

Formerly AMRI, Inc., Curia is an end-to-end global CDMO built to help pharmaceutical and biotech companies bring leading pharma products to market by combining a flexible suite of R&D and manufacturing capabilities with industry-leading expertise.

SECTOR: CDMO
YEAR: 2017
STATUS: Current
PE PARTNER: The Carlyle Group, GTCR

logo – theramed

Theramed Specialty Pharmaceuticals was a Canadian specialty pharma company focused on the acquisition, marketing and distribution of medical products.

SECTOR: Pharmaceuticals
YEAR: 2008
STATUS: Realized
PE PARTNER: N/A

logo – carlin

Carlin Consumer Health is a consumer health business specialized in acquiring and commercializing leading over-the-counter (“OTC”) brands.

SECTOR: Consumer Health
YEAR: February 2022
STATUS: Current
PE PARTNER: Hildred Capital Management, LLC
STRATEGIC PARTNER: The Emerson Group

logo-pai

Pharmaceutical Associates, Inc. (“PAI”) is a generic pharma company that manufactures and markets generic liquid pharmaceuticals.

SECTOR: Pharma
YEAR: November 2019
STATUS: Current

logo-inova

iNova is a pharma company that owns and markets a range of prescription and OTC medicines in Australia, South Africa and Asia.

SECTOR: Pharmaceuticals
YEAR: October 2017
STATUS: Current
PE PARTNER: The Carlyle Group & Pacific Equity Partners

logo-novitium

Novitium is a generic pharma company that identifies, develops, manufactures and markets products.

SECTOR: Pharma
YEAR: December 2017
STATUS: Realized

logo-millicent

Millicent is a platform created for the purpose of building a global pharma company through the acquisition and development of pharma products.

SECTOR: Pharma
YEAR: May 2018
STATUS: Current
PE PARTNER: The Carlyle Group

logo-cadencerx

Cadence Rx is a PBM that elevates and expands the scope of pharmacy benefit management services available in today’s workers’ compensation market.

SECTOR: PBM
YEAR: April 2020
STATUS: Current

logo-welldynerx

WellDyne is an innovative, full-service pharmacy benefit manager.

SECTOR: Pharma Services
YEAR: February 2017
STATUS: Current
PE PARTNER: The Carlyle Group

logo – medpharm

MedPharm is a global contract development and manufacturing organization focusing on topical and transdermal pharmaceutical products.

SECTOR: CDMO
YEAR: January 2024
STATUS: Current
PE PARTNER: Ampersand Capital Partners

logo – eximia

Eximia is a multi-therapeutic, clinical trial site management organization that serves contract research organizations, pharmaceutical and biotech companies.

SECTOR: Pharma Services
YEAR: January 2024
STATUS: Current
PE PARTNER: VSS Capital Partners

logo – americaninj

American Injectables is a contract development and manufacturing organization focusing on sterile injectable pharmaceutical products.

SECTOR: CDMO
YEAR: February 2024
STATUS: Current
PE PARTNER: New Rhein Healthcare Investors

FLEXIBLE + DISCIPLINED

By applying the knowledge gained from our extensive experience, we put insight into action to drive compelling value creation. We have a proven record of creating value for our portfolio companies and investors.

Adding value to our Companies.

icon sourcing - Strategic Capital
ACQUISITION SOURCING
icon relationships - Strategic Capital
STRATEGIC RELATIONSHIPS
icon solutions - Strategic Capital
OPERATIONAL SOLUTIONS
icon partners - Strategic Capital
LONG-TERM PARTNERSHIP

ALIGNED + COMMITTED

Alignment with our firm’s focus and values is the cornerstone to generating compelling returns. We invest a significant amount of our own capital and provide investors access to direct or passive co-investments through strong institutional relationships.

Adding value for our Investors.

icon relations - Strategic Capital
RELATIONSHIPS
icon access - Strategic Capital
ACCESS
icon deal - Strategic Capital
DEAL FLOW
icon synergies - Strategic Capital
SYNERGIES

If you’re seeking opportunities in our sectors of focus, we know what you’re looking for and we know how to find it.